Comparing two laser techniques for prostate surgery
Official title: Prospective and Randomized Analysis of Endoscopic Prostate Enucleation Using Moses 2.0 Technology Versus the New Thulium Fiber Laser in Medium and Large Prostates.
Run by Fundacio Puigvert · NCT06565741 · Data updated 2026-11-12
This study is testing which of two laser surgery techniques works better for men with medium to large prostates who need help with urinary problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 90 Years |
| Sex | Men only |
| Enrollment | 120 (estimated) |
| Sponsor | Fundacio Puigvert Academic / other |
| Locations | 3 sites (Barcelona, BARCELONA and 2 other locations) |
| Status | Recruiting |
| Started | September 3, 2024 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT06565741 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are males aged 40 to 90 years with medium to large prostates and significant lower urinary tract symptoms.
✕Probably not a fit
Patients with a history of urethral stenosis or previous prostate surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of two laser techniques, MoLEP and ThuFLEP, for endoscopic anatomical enucleation of the prostate in men with medium to large prostates. The study will evaluate the enucleation efficiency and perioperative bleeding associated with each technique. A total of 120 male patients aged 40 to 90 years, who are candidates for surgery due to lower urinary tract symptoms, will be randomly assigned to one of the two treatment groups. Follow-up assessments will occur at various intervals post-surgery to monitor outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced recovery times for patients undergoing prostate surgery.
How similar studies have gone: Previous studies have shown promising results with both laser techniques, but this specific comparison is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males aged between 40 and 90 years. * Patients who, due to their lower urinary tract symptoms, are candidates for BPH surgery, including: * Obstructive urinary symptoms evaluated through IPSS with a score \>7 and QoL \> 2 or acute urinary reten on refractory to catheter removal. * Obstructive urinary flow evaluated through uroflowmetry with Qmax\< 15 ml/s, obstruction demonstrated by pressure/flow study, prostatic origin haematuria refractory to medical treatment, or acute urinary retention refractory to catheter removal. * Prostatic volume measured by transabdominal ultrasound, transrectal ultrasound, or magnetic resonance imaging of more than 80 cc. * Prostate-specific antigen (PSA) \< 4 ng/ml, or with multiparametric prostate magnetic resonance imaging reporting PIRADS \< 3 or equal to 3 with PSA density \< 15%. Exclusion Criteria: * Diagnosis, suspicion, or history of urethral stenosis or urethral surgery. * History of prostate surgery or pelvic radiotherapy. * Diagnosis or suspicion of prostate cancer or urothelial cancer. * Body mass index superior to 30.
Where it's running
-
Fundacio Puigvert
Barcelona, Barcelona, Spain Recruiting -
Clinic Hospital of Barcelona
Barcelona, Barcelona, Spain Recruiting -
Hospital Univesitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Ivan Schwartzmann Jochamowitz, MD — Fundacio Puigvert
- Study coordinator: Ivan Schwartzmann Jochamowitz, MD
- Email: ischwartzm@fundacio-puigvert.es
- Phone: 0034934169700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bipolar TURP versus MOSES‑assisted Holmium laser enucleation for enlarged prostate
This trial will test whether MOSES‑assisted Holmium laser enucleation (MoLEP) or bipolar transurethral resection (Bi‑TURP) leads to shorter hospital stays and improved intraoperative outcomes for men with symptomatic benign prostatic hyperplasia and prostate volumes of 40–80 cc.
-
Using a new type of PET scanner for imaging prostate cancer and related conditions
This study is testing a new type of PET scanner to see if it can better detect early signs of prostate cancer and related conditions in patients.
-
Electrical stimulation to reduce urinary incontinence in men after prostate cancer treatment
This study tests if using a device that sends electrical impulses can help men who have had prostate cancer treatment reduce urinary incontinence.
-
Investigating prostate medication effects on gut microbiota
This study is testing how prostate medications affect the gut bacteria in men with prostate issues and whether those bacteria influence how well the medications work.
-
Comparing two treatments for severe urinary symptoms in men with prostate enlargement
This study is testing whether a new heat treatment or a blood vessel blocking procedure can help men with prostate enlargement feel better and improve their urinary symptoms.
-
Profiling imaging factors in prostate cancer treatment outcomes
This study is trying to see if special MRI scans can help doctors better understand and treat prostate cancer in men aged 18 and older.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.